PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.20%
Revenue growth at 50-75% of INTC's 9.81%. Martin Whitman would worry about competitiveness or product relevance.
-6.44%
Negative gross profit growth while INTC is at 1.29%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
0.69%
Positive net income growth while INTC is negative. John Neff might see a big relative performance advantage.
-5.26%
Negative EPS growth while INTC is at 7.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.26%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.57%
Share reduction more than 1.5x INTC's 1.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.27%
Reduced diluted shares while INTC is at 1.24%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.54%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
4.31%
OCF growth under 50% of INTC's 172.81%. Michael Burry might suspect questionable revenue recognition or rising costs.
-94.07%
Negative FCF growth while INTC is at 380.95%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
137.93%
10Y revenue/share CAGR under 50% of INTC's 1000.38%. Michael Burry would suspect a lasting competitive disadvantage.
76.91%
5Y revenue/share CAGR under 50% of INTC's 248.43%. Michael Burry would suspect a significant competitive gap or product weakness.
71.38%
3Y revenue/share CAGR at 50-75% of INTC's 106.24%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
-9.01%
Negative 5Y OCF/share CAGR while INTC is at 468.54%. Joel Greenblatt would question the firm’s operational model or cost structure.
42.84%
3Y OCF/share CAGR under 50% of INTC's 94.59%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
665.18%
10Y net income/share CAGR of 665.18% while INTC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
548.82%
5Y net income/share CAGR above 1.5x INTC's 320.98%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
257.19%
3Y net income/share CAGR above 1.5x INTC's 69.17%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
128.96%
Below 50% of INTC's 552.49%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
49.99%
Below 50% of INTC's 169.01%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
98.79%
3Y equity/share CAGR 1.25-1.5x INTC's 86.43%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
4.56%
Dividend/share CAGR of 4.56% while INTC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
23.92%
Dividend/share CAGR of 23.92% while INTC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.96%
3Y dividend/share CAGR of 29.96% while INTC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.71%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.77%
We show growth while INTC is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.61%
Asset growth above 1.5x INTC's 2.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.79%
50-75% of INTC's 7.78%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-6.21%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Our R&D shrinks while INTC invests at 5.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
40.00%
SG&A growth well above INTC's 29.32%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.